R6/2 huntington's disease mice develop early and progressive abnormal brain metabolism and seizures

Journal of Neuroscience

Volumn 32, Issue 19, 2012, Pages 6456-6467

  Cepeda Prado, Efrain ^a,b   Popp, Susanna ^b   Khan, Usman ^a,c   Stefanov, Dimitre ^b   Rodríguez, Jorge ^a,b   Menalled, Liliana B ^d   Dow Edwards, Diana ^b   Small, Scott A ^c   Moreno, Herman ^a,b  

^a SUNY Downstate Medical Center   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c PsychoGenics Inc ^*  (United States)

^d PSYCHOGENICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN BLOOD VOLUME; BRAIN ELECTROPHYSIOLOGY; BRAIN METABOLISM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENTORHINAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HIPPOCAMPUS; HUNTINGTON CHOREA; HYPOTHALAMUS; MALE; MOTOR CORTEX; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEIZURE; SEIZURE SUSCEPTIBILITY; THALAMUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUNTINGTON DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; OXYGEN CONSUMPTION; SEIZURES; TIME FACTORS;

EID: 84860690256     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0388-12.2012     Document Type: Article

References (66)

1. Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yébenez JG, Boesiger P, Weindl A, Maguire RP (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 119:2085-2095.
2. Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133-1145.
3. Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA (1998) Frontal lobe volume in patients with Huntington's disease. Neurology 50:252-258.
4. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phe-notype in the adult brain and during brain aging. Neuron 68:409-427.
5. Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF (2008) Magnetic resonance imaging asan approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 58:209-225.
6. Chaigneau E, Tiret P, Lecoq J, Ducros M, Knöpfel T, Charpak S (2007) The relationship between blood flow and neuronal activity in the rodent olfactory bulb. J Neurosci 27:6452-6460.
7. Costa DC, Pilowsky LS, Ell PJ (1999) Nuclear medicine in neurology and psychiatry. Lancet 354:1107-1111.
8. Cummings DM, André VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS (2009) Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci 29:10371-10386.
9. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD (2002) Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 125:2332-2341.
10. El Fakhri G, Kijewski MF, Johnson KA, Syrkin G, Killiany RJ, Becker JA, Zimmerman RE, Albert MS (2003) MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol 60:1066-1072.
11. González RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF, Growdon JH, Rosen BR (1995) Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol 16:1763-1770.
12. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234-238.
13. Huppert TJ, Jones PB, Devor A, Dunn AK, Teng IC, Dale AM, Boas DA (2009)Sensitivity of neural-hemodynamic coupling to alterations in ce rebral blood flow during hypercapnia. J Biomed Opt 14:044038.
14. Karow DS, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK, Dale AM (2010) Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology 256:932-942.
15. Kayser C, Kim M, Ugurbil K, Kim DS, König P (2004) A comparison of hemodynamic and neural responses in cat visual cortex using complex stimuli. Cereb Cortex 14:881-891.
16. Kovács R, Rabanus A, Otáhal J, Patzak A, Kardos J, Albus K, Heinemann U, Kann O (2009) Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J Neurosci 29:8565-8577.
17. Lauritzen M (2005) Reading vascular changes in brain imaging: is dendritic calcium the key? Nat Rev Neurosci 6:77-85.
18. Lenz C, Rebel A, van Ackern K, Kuschinsky W, Waschke KF (1998) Local cerebral blood flow, local cerebral glucose utilization, and flow-metabolism coupling during sevoflurane versus isoflurane anesthesia in rats. Anesthesiology 89:1480-1488.
19. Lerch JP, Carroll JB, Spring S, Bertram LN, Schwab C, Hayden MR, Henkel-man RM (2008) Automated deformation analysis in the YAC128 Hun-tington disease mouse model. Neuroimage 39:32-39.
20. Lerch JP, Sled JG, Henkelman RM (2011) MRI phenotyping of genetically altered mice. Methods Mol Biol 711:349-361.
21. Li JY, Popovic N, Brundin P (2005) The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2:447-464.
22. Lin W, Celik A, Paczynski RP (1999) Regional cerebral blood volume: a comparison ofthe dynamic imaging and the steady state methods.J Magn Reson Imaging 9:44-52.
23. Logothetis NK, Pfeuffer J (2004) On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 22:1517-1531.
24. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A (2001) Neuro-physiological investigation of the basis of the fMRI signal. Nature 412:150-157.
25. McCasland JS, Hibbard LS (1997) GABAergic neurons in barrel cortex show strong, whisker-dependent metabolic activation during normal behavior. J Neurosci 17:5509-5527.
26. Menalled LB, Patry M, Ragland N, Lowden PA, Goodman J, Minnich J, Za-hasky B, Park L, Leeds J, Howland D, Signer E, Tobin AJ, Brunner D (2010)Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease showsno benefit from CoQ10orminocycline. PLoS One 5:e9793.
27. Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Invest 121:493-499.
28. Moreno H, Hua F, Brown T, Small S (2006) Longitudinal mapping of mouse cerebral blood volume with MRI. NMR Biomed 19:535-543.
29. Moreno H, Wu WE, Lee T, Brickman A, Mayeux R, Brown TR, Small SA (2007) Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch Neurol 64:1467-1477.
30. Moreno H, Burghardt NS, Vela-Duarte D, Masciotti J, Hua F, Fenton AA, Schwaller B, Small SA (2011) The absence of the calcium-buffering protein calbindin is associated with faster age-related decline in hippocampal metabolism. Hippocampus. Advance online publication. Retrieved March 29, 2012. doi:10.1002/hipo.20957.
31. Mueggler T, Baumann D, Rausch M, Staufenbiel M, Rudin M (2003) Age-dependent impairmentofsomatosensory responseinthe amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease. J Neurosci 23:8231-8236.
32. Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R, Oostra BA (2000) Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41:19-23.
33. Nehlig A, Wittendorp-Rechenmann E, Lam CD (2004) Selective uptake of [14C]2-deoxyglucose by neurons and astrocytes: high-resolution microautoradiographic imaging by cellular 14C-trajectography combined with immunohistochemistry. J Cereb Blood Flow Metab 24:1004-1014.
34. Paxinos G, Franklin KBJ (2001) The mouse brainin stereotaxic coordinates, Ed 2. San Diego: Academic.
35. Piilgaard H, Lauritzen M (2009) Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. J Cereb Blood Flow Metab 29:1517-1527.
36. Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS (2007) Selective defect of in vivo glyco-lysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A 104:2945-2949.
37. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
38. Rapoport SI (2000) Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 97:5696-5698.
39. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752-758.
40. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615-1620.
41. Rostrup E, Knudsen GM, Law I, Holm S, Larsson HB, Paulson OB (2005) The relationship between cerebral blood flow and volume in humans. Neuroimage 24:1-11.
42. Rothman DL, Behar KL, Hyder F, Shulman RG (2003) In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol 65:401-427.
43. Sabuncu MR, Yeo BT, Van Leemput K, Vercauteren T, Golland P (2009) Asymmetric image-template registration. Med Image Comput Comput Assist Interv 12:565-573.
44. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA (2009a) Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease. Neurobiol Dis 33:12-19.
45. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA (2009b) Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neu-robiol Dis 33:20-27.
46. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001-1012.
47. Simonsen CZ, Ostergaard L, Smith DF, Vestergaard-Poulsen P, Gyldensted C (2000) Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking. J Magn Reson Imaging 12:411-416.
48. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME (2000a) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 97:6037-6042.
49. Small SA, Nava AS, Perera GM, Delapaz R, Stern Y (2000b) Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging. Microsc Res Tech 51:101-108.
50. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neuro-chem 28:897-916.
51. Tian P, Teng IC, May LD, Kurz R, Lu K, Scadeng M, Hillman EM, De Cre-spigny AJ, D'Arceuil HE, Mandeville JB, Marota JJ, Rosen BR, Liu TT, Boas DA, Buxton RB, Dale AM, Devor A (2010) Cortical depth-specific microvascular dilation underlies laminar differences in blood oxygen-ation level-dependent functional MRI signal. Proc Natl Acad Sci U S A 107:15246-15251.
52. Tkac I, Dubinsky JM, Keene CD, Gruetter R, Low WC (2007) Neurochem-ical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem 100:1397-1406.
53. Torres-Reverón A, Melnick SM, Stephenson SI, Dow-Edwards DL (2006) Standardization of a novel blood-sampling method through the jugular vein for use in the quantified [14C] 2-deoxyglucose method. J Neurosci Methods 150:143-149.
54. van Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Uluǧ AM, Traystman RJ, Kaup-pinen RA (1998) Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med 4:159-167.
55. Vlachos F, Tung YS, Konofagou EE (2010) Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI. Phys Med Biol 55:5451-5466.
56. Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369-384.
57. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington's disease. J Neu-ropathol Exp Neurol 44:559-577.
58. Weinstein BM (2005) Vessels and nerves: marching to the same tune. Cell 120:299-302.
59. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR (1994) Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 31:601-610.
60. Wu EX, Wong KK, Andrassy M, Tang H (2003) High-resolution in vivo CBV mapping with MRIinwild-type mice. Magn Reson Med 49:765-770.
61. Wu W, Small SA (2006) Imaging the earliest stages of Alzheimer's disease. Curr Alzheimer Res 3:529-539.
62. Yan QJ, Asafo-Adjei PK, Arnold HM, Brown RE, Bauchwitz RP (2004) A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 3:337-359.
63. Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC (2005) Quantitative pharmacokinetic analysis ofDCE-MRI data without an arterial input function:a reference region model. Magn Reson Imaging 23:519-529.
64. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116-1128.
65. Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA (2011) Impaired brain creatine kinase activity in Huntington's disease. Neuro-degener Dis 8:194-201.
66. Zimbelman JL, Paulsen JS, Mikos A, Reynolds NC, Hoffmann RG, Rao SM (2007) fMRI detection of early neural dysfunction in preclinical Hun-tington's disease. J Int Neuropsychol Soc 13:758-769.